Exosome Diagnostics
New York
About Exosome Diagnostics
Exosome Diagnostics is developing biofluid-based molecular diagnostic tests for use in personalized medicine. Exosomes and other microvesicles are shed into all biofluids, including blood, urine and cerebrospinal fluid, forming a highly enriched source of intact, disease-specific nucleic acids. The Company's proprietary exosome technology makes use of this natural enrichment to achieve high sensitivity and specificity for rare gene transcripts and the expression of genes responsible for cancers and other diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $112.1M
- Funding stage: M&A
- Last round: Series C (Jul 2017)
- Website: exosomedx.com
- Phone: 1(617) 588-0500
Industries & Categories
Biotechnology, Genetics, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/exosome-diagnostics-43084 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.